9 January 2020 in Current Pharmaceutical Design
Background: Hepatocellular carcinoma (HCC) is one of the most deadly cancer types worldwide, and its incidence is high in China. Multiple long non-coding RNAs (lncRNAs) have been recently identified as crucial oncogenic factors or tumor suppressors. In this study, we explored the effects of LncRNA RHPN1 antisense RNA 1 (RHPN1-AS1) on the progression of HCC. Method: Expression levels of RHPN1-AS1 and miR-596 in HCC samples were measured by qRT-PCR. The association between pathological indexes and the expression level of RHPN1-AS1 was also analyzed. Human HCC cell lines Huh7 and SMMC-7721 were used as cell models. CCK-8 and colony formation assays were performed to assess the effect of RHPN1-AS1 on HCC cell line proliferation. The flow cytometer instrument was used to study the effect of RHPN1-AS1 on apoptosis of HCC cells. The transwell assay was conducted to detect the effect of RHPN1-AS1 on migration and invasion. Furthermore, luciferase reporter assay was used to confirm targeting of miR-596 by RHPN1-AS1. Additionally, the regulatory function of RHPN1-AS1 on insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) was detected by western blot. Result: The expression level of RHPN1-AS1 in HCC samples was observed to significantly increase compared with normal tissues and its high expression was correlated with unfavorable pathological indexes. Highly expressed RHPN1-AS1 was associated with shorter overall survival time. RHPN1-AS1 overexpression remarkably accelerated proliferation and metastasis of HCC cells, while reduced apoptosis. Accordingly, RHPN1-AS1 knockdown suppressed the malignant phenotypes of HCC cells. RHPN1-AS1 overexpression significantly reduced miR-596 expression by sponging it, but enhanced IGF2BP2 expression. Conclusion: RHPN1-AS1 acts as a sponge of tumor suppressor miR-596 in HCC that can indirectly enhance the IGF2BP2 expression and function as an oncogenic lncRNA.
23 March 2020 in IEEE Geoscience and Remote Sensing Magazine
The ZiYuan3 (ZY3) is a civilian stereo surveying and mapping satellite from China operating under the framework of the Earth resources satellite series, and its objective is to fulfill 1:50,000 mapping and update largerscale fundamental geographic information products. This article introduces the ZY3-03 satellite's mission and payload specifications as well as its data utilization and distribution policy. In the future, the ZY3-03 will realize the demands of China's national economic and social development and play an important role in the fields of Earth observation and environmental protection.
1 October 2021 in Science of Advanced Materials
MiRNA-34b-T cell restricted intracellular antigen-1-stress granules (miRNA-34b-TIA-1-SG) superparamagnetic iron oxide nanoparticles were studied in this project and their directional function will provide a new carrier for improving directional improvement of interventional therapeutic drugs for breast cancer. We explored its therapeutic effect on breast cancer treatment through the following groups; Group I: blank control group (injected with 0.9% normal saline 0.5 mL to the tail vein), Group II: miRNA-34b-TIA-1-SG group (superparamagnetic iron oxide miRNA-34b-TIA-1-SG nanoparticles given by tail vein injection), Group III: superparamagnetic iron oxide-oriented miRNA-34b-TIA-1-SG group (superparamagnetic iron oxide nanoparticles given by tail vein injection). In vitro experiment involved the following methods: MTT, flow cytometry and colony formation experiment, all used to evaluate biological processes of tumor cells after tail vein injection of superparamagnetic iron oxide directed miRNA-34b-TIA-1-SG. In vivo experiments involved the following: tumor xenotransplantation experiment, used to observe the effect of tail vein injection of superparamagnetic iron oxide-oriented miRNA-34b-TIA-1-SG on the treatment effect of breast cancer. Both In vivo experiments and In vitro experiments in MDA-MB-231 cells confirmed that superparamagnetic iron oxide-oriented miRNA-34b-TIA-1-SG nanoparticles effectively inhibited breast cancer cells proliferation and colony formation, and also promoted cell apoptosis. Promotion of cell apoptosis is one of the main ways to treat breast cancer, as appearance of stress granules inhibits cell apoptosis, so regulating stress granules to promote the apoptosis of breast cancer cells is an important treatment strategy. TIA-1 is an essential component of stress granules, and miRNA-34b was significantly down-regulated in breast cancer cells. Therefore, the hypothesis that miRNA-34b-TIA-1-SG signal axis regulates cell apoptosis and promotes breast cancer cell proliferation is herein proposed. We constructed the miRNA-34b reporter gene system, and our study showed that the superparamagnetic iron oxide oriented miRNA-34b-TIA-1-SG nanoparticles may be used as a development direction for breast cancer treatment, which may provide a new and highly effective molecular-oriented drug.